Dr. Adam Brian Levitt, MD

Dr. Levitt practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Levitt's NPI, 1881673077, was assigned on January 16, 2006. Dr. Levitt graduated from Tufts University School Of Medicine in 1997. Dr. Levitt holds Florida license ME91525.

Dr. Levitt's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Levitt's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Levitt is also affiliated with Orlando Regional Medical Center. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Levitt to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levitt practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Levitt's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Levitt is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Levitt's licenses on file in 4 states: Florida, Arizona, Georgia and District of Columbia.

Dmand AI lists amputation, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, deep vein thrombosis (DVT), leg revascularization and lymphedema among the conditions Dr. Levitt treats.

CMS data shows 2,285 Medicare services from Dr. Levitt across 21 procedure codes in 2024, for 330 Medicare patients. Medicare paid $68,002 for them.

CMS counts 330 Medicare patients who saw Dr. Levitt in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levitt's median patient age at 70, with 46% women.

In 2024, Dr. Levitt wrote 345 Medicare Part D claims for 154 patients. 89% of them were for generic drugs. CMS names the drug for 272 of them, across 5 drugs with 11 or more claims each, at $20,475 in total drug cost. In 2023, CMS named 369 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Levitt for performance year 2024, reported individually. Dr. Levitt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of leg revascularization (restoring blood flow) by Dr. Levitt, more than 70% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Levitt. The most frequent topics are Blood Vessel Prosthesis Implantation, Stents and Angioplasty. Dr. Levitt has published most often in J Vasc Surg. Dr. Levitt's most frequent co-authors are Kin Man Lai, MD, John D. Martin, MD and Peter J. Schubart, MD, PhD.

CMS Open Payments shows 265 general payments to Dr. Levitt from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. W. L. Gore & Associates, Inc. paid the most, $5,370.

Dmand AI lists 1 award for Dr. Levitt.

Dr. Levitt graduated from Tufts University School Of Medicine in 1997. Dr. Levitt is a member of ACS and SVS.

Dr. Levitt is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.